Blackford D. Gary's most recent trade in Avanos Medical Inc was a trade of 12,003 Common Stock done . Disclosure was reported to the exchange on Jan. 2, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Avanos Medical Inc | Gary D. Blackford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 12,003 | 71,593 (0%) | 0% | 0 | Common Stock | |
Avanos Medical Inc | Blackford D. Gary | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 8,378 | 59,590 (0%) | 0% | 0 | Common Stock | |
Avanos Medical Inc | Gary D. Blackford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 7,008 | 51,212 (0%) | 0% | 0 | Common Stock | |
Avanos Medical Inc | Gary D. Blackford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 5,354 | 44,204 (0%) | 0% | 0 | Common Stock | |
ReShape Lifesciences Inc. | Gary D. Blackford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2021 | 253,429 | 253,429 (71%) | 71% | 0 | Common Stock, $0.001 par value per share | |
Avanos Medical Inc | Gary D. Blackford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 4,005 | 38,850 (0%) | 0% | 0 | Common Stock | |
Avanos Medical Inc | Gary D. Blackford | Director | Purchase of securities on an exchange or from another person at price $ 29.00 per share. | 08 May 2020 | 5,000 | 29,845 (0%) | 0% | 29 | 145,000 | Common Stock |
Avanos Medical Inc | Gary D. Blackford | Director | Purchase of securities on an exchange or from another person at price $ 28.50 per share. | 08 May 2020 | 5,000 | 34,845 (0%) | 0% | 28.5 | 142,500 | Common Stock |